← FDA ENFORCEMENT
Z-3047-2026Class II

Diagnostica Stago, Inc.

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
Diagnostica Stago, Inc.
Product type
Device
Status
Ongoing
Report date
2026-09-09
Distribution
US Nationwide distribution in the states and territory of NJ, NY, NJ, VA, PA, FL, AL, GA, TN, OH, IL, MO, NE, TX, CO, UT, CA, PR.
Firm state
NJ
Product quantity
5220 units
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Validation & Qualification
Reason for recall

A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

Product description

STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test

Code / lot info

UDI : (01)3607450007466(11)250331(17)270331(10)273074(241)00746, Exp 3/31/2027

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →